Highlights
NASDAQ: CNCE       Concert Pharmaceutic
Last Price Today's Change   Day's Range   Trading Volume
19.71   -0.23 (1.15%)  18.77 - 20.255  514,574

Overview

 
Avg Volume (4 weeks):658,700
4 Weeks Range:18.77 - 28.40
4 Weeks Price Volatility (%):
9.76%
52 Weeks Range:8.61 - 30.71
52 Weeks Price Volatility (%):
50.23%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. The Company's deuterated chemical entity platform (DCE Platform), has potential across various therapeutic areas. Its product candidates include AVP-786, CTP-656, CTP-730, CTP-543 and JZP-386. The Company's product candidate, CTP-656, is a next generation potentiator that it is initially developing for the treatment of cystic fibrosis in patients having gating mutations, including the G551D mutation. CTP-543 was discovered by applying Concert's deuterium chemistry technology to modify ruxolitinib. AVP-786 is a combination of a dextromethorphan and an ultra-low dose of quinidine. CTP-730 is a phosphodiesterase 4 (PDE4) inhibitor that has potential for the treatment of various inflammatory diseases.

  Be the first to like this.
 


 

2624  4741  579  572 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 16.77-0.58 
 SPY 279.14-0.47 
 BAC 31.48+0.30 
 F 12.07-0.11 
 AMD 12.47+0.29 
 VXX 26.96+0.13 
 UVXY 9.43+0.09 
 GNC 5.26+1.79 
 XLF 29.33-0.04 
 GDX 23.61-0.33 
Partners & Brokers